Summary & Overview
HCPCS L8692: Auditory Osseointegrated External Sound Processor
HCPCS Level II code L8692 identifies an external, body-worn auditory osseointegrated device sound processor intended for use without osseointegration and supplied with a headband or other external attachment. This device category matters nationally because it represents a non-implant alternative for patients with conductive, mixed, or single-sided hearing loss, and it involves intersectional coverage considerations across commercial insurers and Medicare for durable medical equipment and prosthetic-related benefits. Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise overview of the code’s clinical role, typical sites of service, and service type. The publication summarizes payer coverage patterns, common billing modifiers in use, and relevant policy or coding updates where available. It also outlines typical documentation and billing elements associated with supplying an external auditory osseointegrated sound processor and highlights areas where coverage language commonly varies across payers. Data not available in the input is identified explicitly for transparency.
Billing Code Overview
HCPCS Level II code L8692 describes an auditory osseointegrated device external sound processor that is body worn and intended for use without osseointegration, and it includes a headband or other means of external attachment. This device provides an external solution for individuals with conductive, mixed, or single-sided sensorineural hearing loss who use a non-implanted, headband- or attachment-mounted sound processor.
Service Type: Durable medical device / external hearing prosthesis
Typical Site of Service: Outpatient clinics, audiology centers, durable medical equipment suppliers, and other ambulatory care settings
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with conductive or mixed hearing loss who is not a candidate for or declines surgical osseointegration and requires an external, body‑worn auditory osseointegrated sound processor attached via headband or other external means. The patient often presents to an otolaryngology or audiology clinic with a history of chronic otitis media, external auditory canal atresia, ossicular discontinuity, or persistent conductive hearing deficit after tympanoplasty. Initial evaluation includes history, physical exam, and diagnostic audiology (pure tone and speech audiometry). A trial with a non‑implantable bone conduction device or headband‑mounted processor is fitted by an audiologist to assess aided benefit. The device categorized by L8692 is dispensed by a durable medical equipment (DME) supplier or audiology clinic when the patient elects a non‑surgical, body‑worn solution.
Typical clinical workflow:
-
Patient referred to otolaryngology or audiology for conductive/mixed hearing loss evaluation.
-
Audiometric testing confirms conductive or mixed pattern with air‑bone gap and measurable bone conduction thresholds.
-
Trial fitting of bone conduction processor on headband conducted in clinic to document functional benefit.
-
If benefit demonstrated and patient declines or is not a surgical candidate for osseointegration, order for
L8692is placed with appropriate clinical justification. -
DME supplier or audiologist dispenses the body‑worn external sound processor, provides device orientation and fitting, and documents medical necessity, device model, and accessories (headband or attachment).
-
Follow‑up visits with audiology for verification, adjustments, and routine maintenance; replacement or repair services billed per payer policy.